Ogorek Anthony Joseph Ligand Pharmaceuticals Inc Transaction History

Ogorek Anthony Joseph

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 26, 2021	SELL	$99.52 - $215.83 $4,179 - $9,064	-42 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$89.56 - $126.72 $3,761 - $5,322	42 New	42 $4,000
Q2 2020 Aug 07, 2020	SELL	$68.28 - $123.65 $2,867 - $5,193	-42 Closed	0 $0
Q2 2018 Jul 12, 2018	BUY	$150.77 - $207.98 $6,332 - $8,735	42 New	42 $8,000

275

18.5M

30.8K

5.2K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.95B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Ogorek Anthony Joseph , based on Form 13F filings with the SEC.

Stay updated on Ogorek Anthony Joseph with notifications on news.